MyMD Pharmaceuticals announced that it received notice from Nasdaq on March 4 informing the company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on the Nasdaq Capital Market.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MYMD:
